mr. walden: mr. chairman, i appreciate that. i know there are a lot of amendments that came through the system. i'm trying to figure out what the issue is here. i know there were, you know, i think we offered 16 amendments and got one. democrats got 25 amendments. had one technical amendment through the rules committee. and cot parliamentarians perhaps tell me -- could the parliamentarians perhaps tell me, or somebody explain what the problem is here and why we have to correct it here on the floor? guess that's my question. the chair: the gentleman may yield on his reservation. mr. walden: yes. the chair: the gentleman from florida is recognized. mr. deutch: thank you, mr. chairman. mr. walden: i yield to the gentleman from florida, is that right? the chair: yes. mr. deutch: mr. chairman, the amendment is a technical amendment to address a drafting error so that it's conforming and so that there will be no problems going forward. mr. walden: i withdraw my reservation, mr. chairman. mr. deutch: i than

mr. walden: mr. chairman, how much time does each side have? the chair: the gentleman from oregon has nine minutes. the gentleman from new jersey as one minute. mr. walden: does the gentleman have other speakers? no. then i yield myself such time as i may consume. the chair: the gentleman is recognized. mr. walden: thank you, mr. chairman. let me address a few issues. first, my friend from new jersey, and he is my friend, referenced my amendment. it's unfortunate we couldn't debate my amendment because the rules committee wouldn't allow us to bring it to the floor nor a bill i offered that has more than 100 co-sponsors that would make sure that pre-existing condition prist are protected in case -- pre-existing conditions are protected in case the court decision in texas goes against the a.c.a. and wipes out those protections. see, this would be an insurance policy for people with pre-existing conditions in public law. we could do that today. if it has some shortcomings, then let's have a markup on th

mr. walden: mr. chairman, i'll reserve. the chair: the gentleman from oregon reserves. the gentleman from new jersey is ecognized. mr. pallone: i yield a minute and a half to the gentleman from vermont, mr. welch. the chair: the gentleman is recognized. well well -- mr. welch: this legislation is going to make health care more affordable and more accessible. two things, one, we finally are attacking the explosion in the cost of prescription drugs and i thank my republican colleagues in participating in that effort. in vermont, we just had a 16% rate increase request from blue cross/blue shield, 9% of that is attributable to the increase in phrma costs. phrma has been ripping us off. and this bill ends their abuse of outrageous practice of paying generic practice to delay bringing their lower cost drugs to the market. no excuse for that. this bill ends it. the second thing it does is deny them the opportunity to withhold samples so generic companies can come up with a competitive product. that is trem

mr. walden: mr. chairman, i'll reserve. the chair: the gentleman from oregon reserves. the gentleman from new jersey is ecognized. mr. pallone: i yield a minute and a half to the gentleman from vermont, mr. welch. the chair: the gentleman is recognized. well well -- mr. welch: this legislation is going to make health care more affordable and more accessible. two things, one, we finally are attacking the explosion in the cost of prescription drugs and i thank my republican colleagues in participating in that effort. in vermont, we just had a 16% rate increase request from blue cross/blue shield, 9% of that is attributable to the increase in phrma costs. phrma has been ripping us off. and this bill ends their abuse of outrageous practice of paying generic practice to delay bringing their lower cost drugs to the market. no excuse for that. this bill ends it. the second thing it does is deny them the opportunity to withhold samples so generic companies can come up with a competitive product. that is trem

mr. walden: i reserve the balance of my time. the chair: the gentleman reserves the balance of his time. the gentleman from new jersey. mr. malinowski: i reserve. the chair: the gentleman reserves the balance of his time. the gentleman from oregon. mr. walden: i reserve. the chair: the gentleman reserves the balance of his time. the gentleman from new jersey. mr. malinowski: i'll close by saying there's no question whatsoever what the administration intends to do. they have been trying from day one from january of 2017, to repeal the affordable care act and its essential protectioners in american people. the only thing that's changed is that it's become politically impossible for anyone in america to say that you are opposed to protecting people with pre-existing conditions. so the war against health care protections is being covered up by war against the english language. everyone says, we're for pre-existing conditions. yet every single step the administration and its supporters take is designed to weaken those protections. thi

mr. walden: thank you, mr. chairman. so let's talk about the navigator program. they enroll less than 1% today. less than 1%. "wall street journal" reported an investigation that one grantee took in $200,000 to enroll a grand total of one person. and they found the top 10 most expensive navigators collected $2.77 million taxpayer dollars. $2.77 million. do you know how many people they signed up? 314. they want to add $25 million $62,500,000 the in grants. we're talking about less than 1%. they say, oh, we got to educate people about their options. then, they put a gag rule in here saying we talk about short-term duration plans. no, you can't know about that. no, we're going to stop that. oh, you can't know about association health plan options either. might be better for you and your family and actually be more affordable. no, no. because that's not our federal decision here. they decide and they don't want you to even know so navigators can't talk about those things. that's gagged in this law. the amazing thing we neve

mr. walden: thank you, mr. speaker. republicans and democrats worked together on provisions to bring generic drugs to market faster. and to stop abusive practices. we did that on the energy and commerce committee and we brought this house multiple bills to achieve that goal and we did it unanimously. we believe our bipartisan work will increase competition and ultimately help lower the cost of prescription drugs. these policies passed unanimously out of the energy and commerce committee. they help consumers and they have the added benefit of helping the federal government by producing $4 billion in savings. unfortunately our friends on the other side of the aisle, democrats, decided to pair these bipartisan bills to lower drug costs with what they knew were very partisan bills that i frankly think waste taxpayer money in many cases. we ought to be working together on this, not descending into partisan politics on a seemingly bipartisan issue. those are the words of stat news as reported today. the fact is, when we do wo

mr. walden: thank you, mr. chairman. i'll continue to reserve time. the chair: the gentleman reserves the balance of his ime. the gentleman from new jersey is ecognized. mr. pallone: thank you, mr. chairman. i yield now two minutes to the gentleman from california, mr. peters. the chair: the gentleman from california is recognized for two minutes. mr. peters: thank you, mr. speaker. and thank you to mr. pallone for yielding. president trump has made clear what climate action he doesn't like. he doesn't like the paris agreement, which contemplated that every nation in the world would set a target to reduce greenhouse gas emissions. he doesn't like the clean power plan which encourages each state to create its own strategy to lower greenhouse gas emissions. and he doesn't like the cafe standards that required automakers to lower emissions from cars and trucks. last month the president's own e.p.a. administrator came to the energy and commerce committee and he testified and he agreed that climate change is happening and tha

mr. walden: thank you, mr. chairman. clearly today is unfortunately more about politics of climate change than rolling up our sleeves and getting to work on american solutions. climate change is real. but addressing climate change should not involve binding ourselves to international agreements that put united states workers and jobs at a disadvantage to our main competitors around the world and with no regard to the cost for american consumers and rate payers. we should have a serious solutions-oriented discussion about thousand address climate change risks through american innovation. american conservation. and preparation. but we all know that long-term sustainable policy is best developed through a thoughtful, logical, strong, bipartisan process. that's the approach we have taken over the last several congresses as republicans. the one i think we should continue in this congress. in fact in the last congress republicans worked with democrats to remove regulatory barriers to new technological advances in power generat

walden for five minutes. >> thank you, madam chair. >> i've got a question to miss -- mr. holtz-eakin and ms. feldman. hr 2064 is -- i'm worried that the bill will have unintended consequences for patients. manufacturers of drugs and -- often provide samples to providers that help low income patients who may have trouble accessing a therapy. either because they lack insurance or the insurance does not provide robust coverage for a drug or device. yet the bill places new reporting requirements on manufacturers. my question is, doesn't this bill create a perverse incentive for manufacturers to not provide samples to physician offices and can you describe how low-income patients benefit from samples provided by drug and device manufacturers and any other unintended consequences? i throw that out to you. >> thank you for that question. very briefly, i think there is a real question as to whether this could cause the lessening of provision of samples. i would also note that significant amount of information is already reported to the fda with regard to samples. in some respects

i want mr. potts and ms. walden to answer this question very quickly and then ms. clark. what must the doj do. questions about generally how social media companies like facebook can take down hate speech and likewise google just precisely so i can give her two stocks. >> thank you, congresswoman. there's no place for hate or violence. we act swiftly through our a.i. and human removers to remove that -- we are going to remove it swiftly. >> thank you. >> we also use a combination of a.i. and human content, and we promote counter-speech across the platform. >> the department of justice must come to the aid of law enforcement. they themselves should be bringing more cases accountable. the fbi should abandon the black identity extremist designation and most importantly use their bully pulpit to speak out and incentivize better data collection. >> thank you. burning churches, thank you. the gentleman from ohio, mr. chabbot. >> i reject white supremacy and all forms of hate. i'm quite sure that my colleagues on the dais share my view. you didn't start off on the conservative si

i would also like, mr. speaker to pay tribute to the former , labour mp for birmingham, all saints, brian walden, who passed away this week. he was a very formidable figure in this house and a very strong political interviewer which every politician really loved being interviewed by at the time but they only said that , afterwards. i think, mr. speaker it would only be right that the house of commons pays tribute to a leading hollywood icon and campaign for what animal welfare doors day. i am quoted to -- tempted to quote some doris day songs, but i won't. [interruption.] all all right, with crack away. -- whip crack away. [speaking simultaneously] i do apologize, mr. speaker. i have obviously started a parliamentary singalong here. speaking of icons, mr. speaker, it would be right to acknowledge it is 40 years since the friends of huddersfield and birkenhead were both elected to this parliament for the first time in the 1979 election. mr. speaker, in the last two years, nine of the u.k.'s richest hedge fun